Specimen Stability Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

124 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-11-30

Study Completion Date

2013-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To collect and process urine samples from critically ill subjects for use in assessing the effects of various urine sample freezing and storage conditions on biomarker test results.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Urine Sample Processing Study

NCT05483088

Acute Kidney Injury

COMPLETED

A Sample Collection Study to Validate the Astute Medical NephroCheck Test in Critically Ill Subjects at Risk for Acute Kidney Injury

NCT01573962

Acute Kidney Injury

COMPLETED

Evaluation of Novel Biomarkers From Acutely Ill Patients at Risk for Acute Kidney Injury

NCT01209169

Acute Kidney Injury

COMPLETED

Identification and Validation of Biomarkers of Acute Kidney Injury Recovery

NCT01868724

Acute Kidney Injury

COMPLETED

A Urine Sample Collection Study in Apparently Healthy Adults and Adults With Chronic, Stable Morbidities

NCT05853016

Healthy Chronic Disease

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Kidney Injury

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Males and females 21 years of age or older
2. Subjects must be enrolled (first study-specific sample collection) within 24 hours of ICU admission

* Subjects enrolled from ED or Floor must be admitted to the ICU within 24 hours of enrollment
* Subjects enrolled in the ICU must have been admitted to the ICU or transferred into the study ICU from another ICU no more than 24 hours prior to enrollment
3. Expected to remain in the ICU for at least 48 hours after enrollment
4. Use of indwelling urinary catheter as standard care expected for at least 48 hours after enrollment
5. Subject (or authorized representative)able and willing to provide written informed consent for study participation

Exclusion Criteria

1. Special populations including children, pregnant women, and prisoners
2. Previous renal transplantation
3. Already receiving dialysis (either acute or chronic) or in imminent need of dialysis at the time of enrollment
4. Known infection with human immunodeficiency virus (HIV) or active hepatitis (acute or chronic)
5. Subjects with a history of chronic kidney disease (CKD) without a baseline serum creatinine value (baseline within 6 months of enrollment)
6. Previously provided a urine sample and enrolled in this study

Minimum Eligible Age

21 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No